Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125945341 | 12594534 | 1 | I | 20160714 | 20160726 | 20160726 | EXP | GB-MHRA-ADR 23556586 | GB-TEVA-677606ACC | TEVA | 74.00 | YR | M | Y | 0.00000 | 20160726 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125945341 | 12594534 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 500 MILLIGRAM DAILY; STARTED 6 WEEKS AGO. | U | 78101 | 250 | MG | BID | |||||||
| 125945341 | 12594534 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 1500 MILLIGRAM DAILY; | U | 78101 | 750 | MG | BID | |||||||
| 125945341 | 12594534 | 3 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 1000 MILLIGRAM DAILY; | U | 78101 | 500 | MG | BID | |||||||
| 125945341 | 12594534 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125945341 | 12594534 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125945341 | 12594534 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125945341 | 12594534 | Dysuria | |
| 125945341 | 12594534 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125945341 | 12594534 | 1 | 201605 | 0 |